Increased endothelial cell permeability in endoglin-deficient cells

FASEB Journal

Volumn 29, Issue 9, 2015, Pages 3678-3688

  Jerkic, Mirjana ^a,b,c   Letarte, Michelle ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

RhoA; TGF 1; TSP 1; VEGF

Indexed keywords

ENDOGLIN; P21 ACTIVATED KINASE; RAC2 PROTEIN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBOSPONDIN 1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; ENDOGLIN PROTEIN, MOUSE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, MOUSE; SIGNAL PEPTIDE; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A; VEGFR2 PROTEIN, MOUSE;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HETEROZYGOSITY; HOMOZYGOSITY; MOLECULAR STABILITY; MOUSE; MULTIGENE FAMILY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; ANIMAL; ANIMAL EMBRYO; CAPILLARY PERMEABILITY; CELL LINE; CYTOLOGY; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CAPILLARY PERMEABILITY; CELL LINE; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; RHO GTP-BINDING PROTEINS; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84935036751     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-269258     Document Type: Article

References (60)

1. Gougos, A., and Letarte, M.(1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J. Biol. Chem. 265, 8361-8364
2. Barbara, N. P., and Wrana, J. L., and Letarte, M. (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta super-family. J. Biol. Chem. 274, 584-594
3. Arthur, H. M., Ure, J., Smith, A. J., Renforth, G., Wilson, D. I., Torsney, E., Charlton, R., Parums, D. V., Jowett, T., Marchuk, D. A., Burn, J., and Diamond, A. G. (2000) Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 217, 42-53
4. Li, D. Y., and Sorensen, L. K., Brooke, B. S., Urness, L. D., Davis, E. C., Taylor, D. G., Boak, B. B., and Wendel, D. P. (1999) Defective angiogenesis in mice lacking endoglin. Science 284, 1534-1537
5. Shovlin, C. L. (2010) Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 24, 203-219
6. Oh, S.P., Seki, T., Goss, K.A., Imamura, T., Yi, Y., Donahoe, P.K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., and Li, E. (2000) Activin receptorlike kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97, 2626-2631
7. Rossi, E., Sanz-Rodriguez, F., Eleno, N., Düwell, A., Blanco, F. J., Langa, C., Botella, L. M., Cabañas, C., Lopez-Novoa, J. M., and Bernabeu, C. (2013) Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. Blood 121, 403-415
8. Tian, H., Mythreye, K., Golzio, C., Katsanis, N., and Blobe, G. C. (2012) Endoglin mediates fibronectin/α5b1 integrin and TGF-β pathway crosstalk in endothelial cells. EMBO J. 31, 3885-3900
9. Conley, B.A., Koleva, R., Smith, J.D., Kacer, D., Zhang, D., Bernabéu, C., and Vary, C. P. (2004) Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain. J. Biol. Chem. 279, 27440-27449
10. Rudini, N., Felici, A., Giampietro, C., Lampugnani, M., Corada, M., Swirsding, K., Garrè, M., Liebner, S., Letarte, M., ten Dijke, P., and Dejana, E. (2008) VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J. 27, 993-1004
11. Xu, G., Barrios-Rodiles, M., Jerkic, M., and Turinsky, A. L., Nadon, R., Vera, S., Voulgaraki, D., Wrana, J. L., Toporsian, M., and Letarte, M. (2014) Novel protein interactions with endoglin and activin receptor-like kinase 1: potential role in vascular networks. Mol. Cell. Proteomics 13, 489-502
12. Karabegovic, A., Shinawi, M., Cymerman, U., and Letarte, M. (2004) No live individual homozygous for a novel endoglin mutation was found in a consanguineous Arab family with hereditary haemorrhagic telangiectasia. J. Med. Genet. 41, e119
13. Nagy, J. A., Benjamin, L., Zeng, H., Dvorak, A. M., and Dvorak, H. F. (2008) Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11, 109-119
14. Pece-Barbara, N., Vera, S., Kathirkamathamby, K., Liebner, S., Di Guglielmo, G. M., Dejana, E., Wrana, J. L., and Letarte, M. (2005) Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway. J. Biol. Chem. 280, 27800-27808
15. Hordijk, P. L., Anthony, E., Mul, F. P., Rientsma, R., Oomen, L. C., and Roos, D. (1999) Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J. Cell Sci. 112, 1915-1923
16. Barrios-Rodiles, M., Brown, K. R., Ozdamar, B., Bose, R., Liu, Z., Donovan, R.S., Shinjo, F., Liu, Y., Dembowy, J., Taylor, I.W., Luga, V., Przulj, N., Robinson, M., Suzuki, H., Hayashizaki, Y., Jurisica, I., and Wrana, J. L. (2005) High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307, 1621-1625
17. Liang, W. C., Wu, X., Peale, F. V., Lee, C. V., Meng, Y. G., Gutierrez, J., Fu, L., Malik, A. K., Gerber, H. P., Ferrara, N., and Fuh, G. (2006) Crossspecies vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J. Biol. Chem. 281, 951-961
18. Bustelo, X.R., Sauzeau, V., and Berenjeno, I.M.(2007) GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. BioEssays 29, 356-370
19. Liu, A., and Mosher, D. F., Murphy-Ullrich, J. E., and Goldblum, S. E. (2009) The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia. Microvasc. Res. 77, 13-20
20. Takahashi, K., and Mernaugh, R. L., Friedman, D. B., Weller, R., Tsuboi, N., Yamashita, H., Quaranta, V., and Takahashi, T. (2012) Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 109, 1985-1990
21. Spring, K., Chabot, C., Langlois, S., Lapointe, L., Trinh, N.T., Caron, C., Hebda, J. K., Gavard, J., Elchebly, M., and Royal, I. (2012) Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation. Blood 120, 2745-2756
22. Seghers, L., de Vries, M. R., Pardali, E., Hoefer, I. E., Hierck, B. P., ten Dijke, P., Goumans, M. J., and Quax, P. H. (2012) Shear induced collateral artery growth modulated by endoglin but not by ALK1. J. Cell. Mol. Med. 16, 2440-2450
23. Holmes, K., and Roberts, O. L., Thomas, A. M., and Cross, M. J. (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell. Signal. 19, 2003-2012
24. Bourdeau, A., and Dumont, D. J., and Letarte, M. (1999) A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104, 1343-1351
25. Bourdeau, A., Cymerman, U., Paquet, M. E., Meschino, W., McKinnon, W. C., Guttmacher, A. E., Becker, L., and Letarte, M. (2000) Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am. J. Pathol. 156, 911-923
26. Kim, M.H., Curry, F.R., and Simon, S.I.(2009) Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding. Am. J. Physiol. Cell Physiol. 296, C848-C856
27. Yuan, S. Y., Shen, Q., Rigor, R. R., and Wu, M. H. (2012) Neutrophil transmigration, focal adhesion kinase and endothelial barrier function. Microvasc. Res. 83, 82-88
28. Peter, M. R., Jerkic, M., Sotov, V., Douda, D. N., Ardelean, D. S., Ghamami, N., Lakschevitz, F., Khan, M. A., Robertson, S. J., Glogauer, M., Philpott, D. J., Palaniyar, N., and Letarte, M. (2014) Impaired resolution of inflammation in the Endoglin heterozygous mouse model of chronic colitis. [E-pub ahead of print] Mediators Inflamm. 10.1155/2014/767185
29. Dupuis-Girod, S., Giraud, S., Decullier, E., Lesca, G., Cottin, V., Faure, F., Merrot, O., Saurin, J.C., Cordier, J.F., and Plauchu, H.(2007) Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association. Clin. Infect. Dis. 44, 841-845
30. Mathis, S., Dupuis-Girod, S., Plauchu, H., Giroud, M., Barroso, B., Ly, K. H., Ingrand, P., Gilbert, B., Godenèche, G., and Neau, J. P. (2012) Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation. Clin. Neurol. Neurosurg. 114, 235-240
31. Tong, L., and Tergaonkar, V. (2014) Rho protein GTPases and their interactions with NFkB: crossroads of inflammation and matrix biology. Biosci. Rep. 34, e00115
32. Bryan, B. A., Dennstedt, E., Mitchell, D. C., Walshe, T. E., Noma, K., Loureiro, R., Saint-Geniez, M., Campaigniac, J. P., Liao, J. K., and D'Amore, P. A. (2010) RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J. 24, 3186-3195
33. Varon, C., Basoni, C., Reuzeau, E., Moreau, V., and Kramer, I. J., and Génot, E. (2006) TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA. Exp. Cell Res. 312, 3604-3619
34. Vandenbroucke, E., Mehta, D., Minshall, R., and Malik, A. B. (2008) Regulation of endothelial junctional permeability. Ann. N. Y. Acad. Sci. 1123, 134-145
35. Hornburger, M. C., and Mayer, B. A., Leonhardt, S., Willer, E. A., Zahler, S., Beyerle, A., Rajalingam, K., Vollmar, A. M., and Fürst, R. (2014) A novel role for inhibitor of apoptosis (IAP) proteins as regulators of endothelial barrier function by mediating RhoA activation. FASEB J. 28, 1938-1946
36. Aghajanian, A., and Wittchen, E. S., Campbell, S. L., and Burridge, K. (2009) Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS One 4, e8045
37. Toporsian, M., Gros, R., Kabir, M. G., Vera, S., Govindaraju, K., Eidelman, D. H., Husain, M., and Letarte, M. (2005) A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ. Res. 96, 684-692
38. Toporsian, M., Jerkic, M., Zhou, Y. Q., Kabir, M. G., Yu, L. X., McIntyre, B. A. S., Davies, A., Wang, Y. J., Stewart, D. J., Belik, J., Husain, M., Henkelman, M., and Letarte, M. (2010) Spontaneous adult-onset pulmonary arterial hypertension attributable to hemorrhagic telangiectasia increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia. Arterioscler. Thromb. Vasc. Biol. 30, 509-517
39. Jerkic, M., Sotov, V., and Letarte, M. (2012) Oxidative stress contributes to endothelial dysfunction in mouse models of hereditary hemorrhagic telangiectasia. Oxid. Med. Cell. Longev. 2012, 686972
40. Duong-Quy, S., Bei, Y., Liu, Z., and Dinh-Xuan, A. T. (2013) Role of Rho-kinase and its inhibitors in pulmonary hypertension. Pharmacol. Ther. 137, 352-364
41. Bei, Y., Duong-Quy, S., Hua-Huy, T., Dao, P., Le-Dong, N.-N., and Dinh-Xuan, A. T. (2013) Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease. Physiol. Rep. 1, e00105
42. Schreibelt, G., Kooij, G., Reijerkerk, A., van Doorn, R., Gringhuis, S. I., van der Pol, S., Weksler, B.B., Romero, I. A., Couraud, P. O., Piontek, J., Blasig, I. E., Dijkstra, C. D., Ronken, E., and de Vries, H. E. (2007) Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 21, 3666-3676
43. Kondrikov, D., and Caldwell, R. B., Dong, Z., and Su, Y. (2011) Reactive oxygen species-dependent RhoA activation mediates collagen synthesis in hyperoxic lung fibrosis. Free Radic. Biol. Med. 50, 1689-1698
44. Meng, Y., Li, T., Zhou, G. S., Chen, Y., Yu, C. H., Pang, M. X., Li, W., Li, Y., Zhang, W. Y., and Li, X. (2015) The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway. Antioxid. Redox Signal. 22, 241-258
45. Souchet, M., Portales-Casamar, E., Mazurais, D., Schmidt, S., Léger, I., Javré, J. L., Robert, P., Berrebi-Bertrand, I., Bril, A., Gout, B., Debant, A., and Calmels, T. P. (2002) Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere. J. Cell Sci. 115, 629-640
46. Cheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabeu, C., Massagué, J., and Letarte, M. (1992) Endoglin is a component of the transforming growth factor-betareceptor systeminhuman endothelialcells. J. Biol. Chem. 267, 19027-19030
47. Lee, N. Y., Ray, B., How, T., and Blobe, G. C. (2008) Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J. Biol. Chem. 283, 32527-32533
48. Gregory, A. L., Xu, G., Sotov, V., and Letarte, M. (2014) Review: the enigmatic role of endoglin in the placenta. Placenta 35(Suppl), S93-S99
49. Qin, H., Qu, C., Yamaza, T., Yang, R., Lin, X., Duan, X. Y., Akiyama, K., Liu, Y., Zhang, Q., Chen, C., Chen, Y., Qi, H. H., Feng, X. H., Le, A. D., and Shi, S. (2013) Ossifying fibroma tumor stem cells are maintained by epigenetic regulation of a TSP1/TGF-b/SMAD3 autocrine loop. Cell Stem Cell 13, 577-589
50. Bornstein, P. (2009) Thrombospondins function as regulators of angiogenesis. J. Cell Commun. Signal. 3, 189-200
51. Garg, P., Yang, S., Liu, A., Pallero, M. A., Buchsbaum, D. J., Mosher, D. F., Murphy-Ullrich, J. E., and Goldblum, S. E. (2011) Thrombospondin-1 opens the paracellular pathway in pulmonary microvascular endothelia through EGFR/ErbB2 activation. Am. J. Physiol. Lung Cell. Mol. Physiol. 301, L79-L90
52. Ardelean, D.S., Jerkic, M., Yin, M., Peter, M., Ngan, B., Kerbel, R.S., and Foster, F. S., and Letarte, M. (2014) Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment. Angiogenesis 17, 129-146
53. Takahashi, T., Takahashi, K., St John, P. L., Fleming, P. A., Tomemori, T., Watanabe, T., Abrahamson, D. R., Drake, C. J., Shirasawa, T., and Daniel, T. O. (2003) A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol. Cell. Biol. 23, 1817-1831
54. Kumar, R., and Gururaj, A. E., and Barnes, C. J. (2006) p21-activated kinases in cancer. Nat. Rev. Cancer 6, 459-471
55. Maharjan, S., Kim, K., Agrawal, V., Choi, H. J., Kim, N. J., Kim, Y. M., Suh, Y. G., and Kwon, Y. G. (2013) Sac-1004, a novel vascular leakage blocker, enhances endothelial barrier through the cAMP/Rac/cortactin pathway. Biochem. Biophys. Res. Commun. 435, 420-427
56. Tian, X., Tian, Y., Gawlak, G., Sarich, N., Wu, T., and Birukova, A. A. (2014) Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism. J. Biol. Chem. 289, 5168-5183
57. Birukova, A. A., Xing, J., Fu, P., Yakubov, B., Dubrovskyi, O., Fortune, J. A., Klibanov, A. M., and Birukov, K. G. (2010) Atrial natriuretic peptide attenuates LPS-inducedlung vascularleak: role of PAK1. Am. J. Physiol. Lung Cell. Mol. Physiol. 299, L652-L663
58. Schulte, D., Küppers, V., Dartsch, N., Broermann, A., Li, H., Zarbock, A., Kamenyeva, O., Kiefer, F., Khandoga, A., Massberg, S., and Vestweber, D. (2011) Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J. 30, 4157-4170
59. Lampugnani, M. G., Orsenigo, F., Gagliani, M. C., Tacchetti, C., and Dejana, E. (2006) Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J. Cell Biol. 174, 593-604
60. Rossi, E., Lopez-Novoa, J. M., and Bernabeu, C. (2015) Endoglin involvement in integrin-mediated cell adhesion as a putative pathogenic mechanism in hereditary hemorrhagic telangiectasia type 1 (HHT1). Front. Genet. 5, 457